| Product Code: ETC7226409 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Pharmacogenetic Testing Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 France Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 France Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 France Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 France Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 France Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 France Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 France Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 France Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 France Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 France Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in France |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing among healthcare providers and patients |
4.2.3 Advancements in technology leading to more accurate and affordable testing options |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing in France |
4.3.2 Lack of standardized guidelines for integrating pharmacogenetic testing into clinical practice |
4.3.3 Concerns regarding data privacy and regulatory issues |
5 France Pharmacogenetic Testing Market Trends |
6 France Pharmacogenetic Testing Market, By Types |
6.1 France Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 France Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 France Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 France Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 France Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 France Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 France Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 France Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 France Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 France Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 France Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 France Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 France Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 France Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 France Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 France Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 France Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 France Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 France Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 France Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 France Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 France Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 France Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 France Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 France Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 France Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 France Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 France Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 France Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 France Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 France Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 France Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 France Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 France Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 France Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 France Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 France Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 France Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 France Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 France Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 France Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 France Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 France Pharmacogenetic Testing Market Export to Major Countries |
7.2 France Pharmacogenetic Testing Market Imports from Major Countries |
8 France Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in France |
8.2 Percentage of healthcare professionals trained in pharmacogenetics |
8.3 Rate of adoption of pharmacogenetic testing in different medical specialties |
9 France Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 France Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 France Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 France Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 France Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 France Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 France Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 France Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 France Pharmacogenetic Testing Market - Competitive Landscape |
10.1 France Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 France Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here